Study of afatinib in HER2-mutant non small cell lung cancer (NSCLC)
Latest Information Update: 10 Oct 2018
At a glance
- Drugs Afatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Oct 2018 New trial record
- 26 Sep 2018 Results presented at the 19th World Conference on Lung Cancer